Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2028

2.1.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type

2.2.1 Aspirin

2.2.2 Ibuprofen

2.2.3 Naproxen

2.2.4 Celecoxib

2.2.5 Others

2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)

2.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application

2.4.1 Drug Store

2.4.2 Hospital Pharmacies

2.4.3 Online

2.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

2.5.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)

3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Player

3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Players

3.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2020-2022)

3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2020-2022)

3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Regions

4.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2017-2022)

4.2 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth (2017-2022)

4.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth (2017-2022)

4.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth (2017-2022)

4.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth (2017-2022)

5 Americas

5.1 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)

5.2 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022)

5.3 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022)

6.2 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022)

6.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Country (2017-2022)

7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022)

7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Region (2017-2022)

8.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022)

8.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Regions (2023-2028)

10.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Regions (2023-2028)

10.1.2 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast

10.1.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast

10.1.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast

10.1.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast

10.2 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Country (2023-2028)

10.2.1 United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.2.2 Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.2.3 Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.2.4 Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Region (2023-2028)

10.3.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.3.2 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.3.3 Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.3.4 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.3.5 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.3.6 Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Country (2023-2028)

10.4.1 Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.4.2 France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.4.3 UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.4.4 Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.4.5 Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Region (2023-2028)

10.5.1 Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.5.2 South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.5.3 Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.5.4 Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.5.5 GCC Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.6 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Type (2023-2028)

10.7 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Roche (Genentech)

11.1.1 Roche (Genentech) Company Information

11.1.2 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Roche (Genentech) Main Business Overview

11.1.5 Roche (Genentech) Latest Developments

11.2 Amgen

11.2.1 Amgen Company Information

11.2.2 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Amgen Main Business Overview

11.2.5 Amgen Latest Developments

11.3 B-MS

11.3.1 B-MS Company Information

11.3.2 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 B-MS Main Business Overview

11.3.5 B-MS Latest Developments

11.4 Merck

11.4.1 Merck Company Information

11.4.2 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Merck Main Business Overview

11.4.5 Merck Latest Developments

11.5 Pfizer

11.5.1 Pfizer Company Information

11.5.2 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Pfizer Main Business Overview

11.5.5 Pfizer Latest Developments

11.6 Novartis

11.6.1 Novartis Company Information

11.6.2 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Novartis Main Business Overview

11.6.5 Novartis Latest Developments

11.7 Eli Lilly and Company

11.7.1 Eli Lilly and Company Company Information

11.7.2 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Eli Lilly and Company Main Business Overview

11.7.5 Eli Lilly and Company Latest Developments

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Information

11.8.2 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Johnson & Johnson Main Business Overview

11.8.5 Johnson & Johnson Latest Developments

11.9 GSK

11.9.1 GSK Company Information

11.9.2 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 GSK Main Business Overview

11.9.5 GSK Latest Developments

11.10 Sanofi

11.10.1 Sanofi Company Information

11.10.2 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Sanofi Main Business Overview

11.10.5 Sanofi Latest Developments

11.11 Boehringer Ingelheim

11.11.1 Boehringer Ingelheim Company Information

11.11.2 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Boehringer Ingelheim Main Business Overview

11.11.5 Boehringer Ingelheim Latest Developments

11.12 Zhejiang Jiuzhou Pharmaceutical

11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Information

11.12.2 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Zhejiang Jiuzhou Pharmaceutical Main Business Overview

11.12.5 Zhejiang Jiuzhou Pharmaceutical Latest Developments

12 Research Findings and Conclusion

Table 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Aspirin

Table 3. Major Players of Ibuprofen

Table 4. Major Players of Naproxen

Table 5. Major Players of Celecoxib

Table 6. Major Players of Others

Table 7. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)

Table 10. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)

Table 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Player (2020-2022)

Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Products Offered

Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Regions (2017-2022)

Table 21. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Country (2017-2022)

Table 23. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)

Table 25. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)

Table 27. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Region (2017-2022)

Table 29. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)

Table 31. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)

Table 33. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Country (2017-2022)

Table 35. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)

Table 37. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Table 46. Key Market Challenges & Risks of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Table 47. Key Industry Trends of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Table 48. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share Forecast by Application (2023-2028)

Table 54. Roche (Genentech) Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 55. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 56. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Roche (Genentech) Main Business

Table 58. Roche (Genentech) Latest Developments

Table 59. Amgen Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 60. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 61. Amgen Main Business

Table 62. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Amgen Latest Developments

Table 64. B-MS Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 65. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 66. B-MS Main Business

Table 67. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. B-MS Latest Developments

Table 69. Merck Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 70. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 71. Merck Main Business

Table 72. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Merck Latest Developments

Table 74. Pfizer Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 75. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 76. Pfizer Main Business

Table 77. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Pfizer Latest Developments

Table 79. Novartis Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 80. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 81. Novartis Main Business

Table 82. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Novartis Latest Developments

Table 84. Eli Lilly and Company Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 85. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 86. Eli Lilly and Company Main Business

Table 87. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Eli Lilly and Company Latest Developments

Table 89. Johnson & Johnson Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 90. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 91. Johnson & Johnson Main Business

Table 92. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Johnson & Johnson Latest Developments

Table 94. GSK Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 95. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 96. GSK Main Business

Table 97. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. GSK Latest Developments

Table 99. Sanofi Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 100. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 101. Sanofi Main Business

Table 102. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Sanofi Latest Developments

Table 104. Boehringer Ingelheim Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 105. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 106. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. Boehringer Ingelheim Main Business

Table 108. Boehringer Ingelheim Latest Developments

Table 109. Zhejiang Jiuzhou Pharmaceutical Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors

Table 110. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

Table 111. Zhejiang Jiuzhou Pharmaceutical Main Business

Table 112. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. Zhejiang Jiuzhou Pharmaceutical Latest Developments

List of Figures

Figure 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type in 2021

Figure 7. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Drug Store

Figure 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: Drug Store (2017-2022) & ($ Millions)

Figure 9. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Hospital Pharmacies

Figure 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: Hospital Pharmacies (2017-2022) & ($ Millions)

Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Online

Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: Online (2017-2022) & ($ Millions)

Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021

Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Player in 2021

Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2022 ($ Millions)

Figure 17. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2022 ($ Millions)

Figure 18. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2022 ($ Millions)

Figure 20. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Value Market Share by Country in 2021

Figure 21. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Share by Type in 2021

Figure 22. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021

Figure 23. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Region in 2021

Figure 28. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021

Figure 29. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Country in 2021

Figure 36. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type in 2021

Figure 37. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021

Figure 38. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021

Figure 46. Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 52. APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 53. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 55. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 56. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 59. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 60. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 61. Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 63. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 64. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 65. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 66. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 67. UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 68. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 69. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 70. Spain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 73. Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)